Your browser is no longer supported. Please, upgrade your browser.
Settings
GBT Global Blood Therapeutics, Inc. daily Stock Chart
GBT [NASD]
Global Blood Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.25 Insider Own4.70% Shs Outstand54.21M Perf Week-1.94%
Market Cap2.19B Forward P/E- EPS next Y-3.60 Insider Trans-2.06% Shs Float49.50M Perf Month-18.22%
Income-151.70M PEG- EPS next Q-0.86 Inst Own13.40% Short Float15.15% Perf Quarter3.32%
Sales- P/S- EPS this Y-11.30% Inst Trans39.13% Short Ratio6.04 Perf Half Y-19.44%
Book/sh9.79 P/B4.13 EPS next Y-5.60% ROA-34.60% Target Price80.21 Perf Year41.75%
Cash/sh8.53 P/C4.74 EPS next 5Y37.00% ROE-37.40% 52W Range27.15 - 68.05 Perf YTD2.67%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-40.63% Beta-
Dividend %- Quick Ratio22.10 Sales past 5Y- Gross Margin- 52W Low48.80% ATR2.12
Employees147 Current Ratio22.10 Sales Q/Q- Oper. Margin- RSI (14)34.58 Volatility4.45% 4.52%
OptionableYes Debt/Eq0.00 EPS Q/Q-40.70% Profit Margin- Rel Volume0.58 Prev Close39.75
ShortableYes LT Debt/Eq0.00 EarningsNov 01 AMC Payout- Avg Volume1.24M Price40.40
Recom1.80 SMA20-11.31% SMA50-10.36% SMA200-15.70% Volume726,097 Change1.64%
Aug-06-18Initiated Piper Jaffray Overweight $80
Jun-27-18Reiterated H.C. Wainwright Buy $73 → $125
Jun-27-18Reiterated Cantor Fitzgerald Overweight $69 → $96
May-08-18Reiterated SunTrust Buy $80 → $77
Mar-21-18Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-28-18Reiterated Cantor Fitzgerald Overweight $61 → $72
Feb-14-18Initiated Janney Buy
Jan-23-18Initiated William Blair Outperform
Dec-14-17Reiterated Needham Buy $51 → $70
Dec-01-17Initiated H.C. Wainwright Buy $73
Sep-21-17Initiated Needham Buy $51
Aug-08-17Reiterated JP Morgan Overweight $44 → $46
Apr-18-17Initiated SunTrust Buy $56
Mar-21-17Resumed Wedbush Outperform $73
Mar-16-17Initiated Cantor Fitzgerald Overweight $61
Mar-02-17Initiated Instinet Buy $50
Jan-04-17Initiated JP Morgan Overweight
Nov-01-16Initiated ROTH Capital Buy $47
Oct-25-16Reiterated Wedbush Outperform $66 → $73
Sep-30-16Initiated Wells Fargo Outperform
Sep-18-18 08:20PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Global Blood Therapeutics, Inc. - GBT ACCESSWIRE
Sep-17-18 03:40PM  Oppenheimers 7 Top Stock Picks for September Kiplinger
08:47AM  Are Options Traders Betting on a Big Move in Global Blood (GBT) Stock? Zacks
Sep-14-18 06:07PM  INVESTIGATION ALERT: The Schall Law Firm Announces It is Investigating Claims against Global Blood Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
08:00AM  Today's Research Reports on Trending Tickers: Ironwood Pharmaceuticals and Global Blood Therapeutics ACCESSWIRE
Sep-13-18 06:16PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Global Blood Therapeutics, Inc. GBT Business Wire -7.40%
05:34PM  Bragar Eagel & Squire, P.C. is Investigating Global Blood Therapeutics, Inc. (GBT) on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
04:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Global Blood Therapeutics, Inc. - GBT PR Newswire
12:33PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Global Blood Therapeutics, Inc. (GBT) PR Newswire
Sep-12-18 06:00PM  Bluebird Bio Stock May Have Upside of at Least 60 Percent InvestorPlace
Sep-07-18 04:05PM  GBT Announces Participation at the 2018 Morgan Stanley Global Healthcare Conference GlobeNewswire
Sep-06-18 04:05PM  GBT Announces New Employment Inducement Grants GlobeNewswire -6.50%
08:00AM  GBT Brings Together Sickle Cell Disease Influencers at 7th Annual Sickle Cell Disease (SCD) Therapeutics Conference GlobeNewswire
Sep-05-18 08:30AM  3 Biotech Stocks Ready to Burn Up TheStreet.com
Aug-28-18 10:50AM  Oppenheimers 7 Top Stock Picks for September InvestorPlace
Aug-23-18 08:00AM  Today's Research Reports on Trending Tickers: Immunomedics and Global Blood Therapeutics ACCESSWIRE
08:00AM  GBT Expands Sickle Cell Disease Pipeline with Worldwide Licensing Agreement for Inclacumab for the Treatment of Vaso-occlusive Crisis GlobeNewswire
Aug-21-18 08:00AM  GBT Appoints Heidi L. Wagner as Senior Vice President, Government Affairs and Policy GlobeNewswire
Aug-16-18 08:00AM  Today's Research Reports on Trending Tickers: Cronos Group and Global Blood Therapeutics ACCESSWIRE
Aug-07-18 04:05PM  GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-03-18 04:05PM  GBT Announces New Employment Inducement Grants GlobeNewswire +6.64%
Aug-02-18 06:59PM  Global Blood: 2Q Earnings Snapshot Associated Press
04:05PM  GBT Reports Recent Business Progress and Provides Second Quarter 2018 Financial Results GlobeNewswire
Jul-26-18 03:47PM  A guide to biotechs building boom in South City American City Business Journals
08:20AM  Today's Research Reports on Trending Tickers: Sarepta Therapeutics and Global Blood Therapeutics ACCESSWIRE
08:00AM  Free Technical Insights on BioPharmX and Three Other Biotech Stocks ACCESSWIRE
Jul-04-18 08:00AM  Today's Research Reports on Trending Tickers: Clovis Oncology and Global Blood Therapeutics ACCESSWIRE
Jul-03-18 04:05PM  GBT Announces New Employment Inducement Grants GlobeNewswire
Jun-28-18 08:20AM  Global Blood Therapeutics is making a big gamble on its sickle cell drug MarketWatch +6.03%
08:10AM  Today's Research Reports on Trending Tickers: Global Blood Therapeutics and Cara Therapeutics ACCESSWIRE
Jun-27-18 06:11PM  Why Sangamo Therapeutics and bluebird bio Slipped Lower Today Motley Fool +15.63%
05:14PM  Why Global Blood Therapeutics Surged 10.7% Higher Motley Fool
03:31PM  Why  a $500 Million Bet on a Looser FDA Makes Sense Bloomberg
11:12AM  GBT's drug meets trial goal, investors skeptical of speedy approval Reuters
10:05AM  Global Blood Therapeutics Meets Primary Endpoints In Sickle Cell Study, Seeks Accelerated FDA Approval Benzinga
08:35AM  Implied Volatility Surging for Global Blood Therapeutics (GBT) Stock Options Zacks
07:38AM  Global Blood Therapeutics' sickle cell disease drug succeeds in trial Reuters
07:30AM  GBT Announces Positive Top-line Data from Part A of the Phase 3 HOPE Study of Voxelotor in Sickle Cell Disease GlobeNewswire
Jun-25-18 12:50PM  3 Killer Stocks Trading at Unfair Discounts TheStreet.com -7.02%
Jun-15-18 01:06PM  Here's Why Shares of Global Blood Therapeutics Inc Are Falling Today Motley Fool -14.88%
11:33AM  Global Blood Therapeutics Shares Plunge After Sickle Cell Candidate Shows Reduced Effect Benzinga
02:30AM  GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Association (EHA) Congress GlobeNewswire
Jun-14-18 07:05AM  Free Technical Reports on Gilead Sciences and Three Additional Biotech Equities ACCESSWIRE
Jun-13-18 02:55PM  Hematology Conference Could Spur Some of Biotech's Outperformers Bloomberg
Jun-08-18 08:30AM  GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease (SCD) Program at Foundation for Sickle Cell Disease Researchs 12th Annual Symposium GlobeNewswire
Jun-05-18 04:05PM  GBT Announces New Employment Inducement Grants GlobeNewswire
Jun-04-18 07:35AM  Consolidated Research: 2018 Summary Expectations for ManTech International, Rapid7, Global Blood Therapeutics, CONSOL Coal Resources LP, Ryanair, and Yandex N.V. Fundamental Analysis, Key Performance Indications GlobeNewswire
May-25-18 08:40AM  Implied Volatility Surging for Global Blood Therapeutics (GBT) Stock Options Zacks
May-23-18 03:00AM  Stocks To Watch: Global Blood Therapeutic Sees RS Rating Jump To 83 Investor's Business Daily
May-19-18 10:00AM  Even Momentum Traders Should Study Stock Charts TheStreet.com
May-18-18 07:31PM  Global Blood Therapeutics Incs (NASDAQ:GBT) Profit Outlook Simply Wall St.
May-17-18 10:30AM  GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at 23rd European Hematology Association (EHA) Congress GlobeNewswire
May-11-18 12:25PM  Having Some Good Luck With Biotech Names TheStreet.com +5.66%
May-09-18 01:52PM  Markets Make an Art of Unpredictability TheStreet.com
May-08-18 12:03PM  Markets Confused by Trump's Upcoming Iran Decision TheStreet.com +7.96%
May-07-18 04:58PM  Global Blood: 1Q Earnings Snapshot Associated Press
04:05PM  GBT Reports Recent Business Progress and First Quarter 2018 Financial Results GlobeNewswire
May-04-18 08:30AM  GBT Announces New Employment Inducement Grants GlobeNewswire
Apr-27-18 07:30AM  [$$] Biotechs Make Headway in Battle Against Sickle Cell Disease The Wall Street Journal
Apr-10-18 07:35AM  Factors of Influence in 2018, Key Indicators and Opportunity within Global Blood Therapeutics, Wix, Changyou, BT Group, Golar LNG, and NantHealth New Research Emphasizes Economic Growth GlobeNewswire +7.65%
Apr-03-18 04:05PM  GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire
04:05PM  GBT Announces New Employment Inducement Grants GlobeNewswire
Mar-22-18 08:30AM  Todays Research Reports on Trending Tickers: Global Blood Therapeutics and Sangamo Therapeutics ACCESSWIRE
Mar-21-18 11:59AM  Turning Neutral: Morgan Stanley Downgrades Sarepta, Loxo Oncology, Global Blood Therapeutics Benzinga -5.00%
08:43AM  Why Global Blood Therapeutics (GBT) Could Be Positioned for a Slump Zacks
Mar-15-18 04:05PM  GBT Announces New Employment Inducement Grants GlobeNewswire
07:31AM  Better Know Biotech: 3 Highfliers That Ought to Be on Your Radar Motley Fool
Mar-14-18 08:10AM  Research Report Identifies Supernus Pharmaceuticals, Celestica, Global Blood Therapeutics, BioTime, CyberArk Software, and Tivity Health, Inc. with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-12-18 02:00PM  5 Stocks That Are Showing Signs of Reversing TheStreet.com -5.42%
08:00AM  Global Blood Therapeutics Announces Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Mar-08-18 10:00PM  Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock GlobeNewswire -5.40%
07:23PM  Is Global Blood Therapeutics Incs (NASDAQ:GBT) Liquidity As Good As Its Solvency? Simply Wall St.
04:01PM  Global Blood Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire
Mar-06-18 08:00AM  GBT Appoints Industry Leader David L. Johnson as Chief Commercial Officer GlobeNewswire
Mar-05-18 04:05PM  GBT Announces Participation at Upcoming Investor Conferences in March GlobeNewswire
04:05PM  GBT Announces New Employment Inducement Grants GlobeNewswire
Feb-28-18 05:04AM  Global Blood reports 4Q loss Associated Press
Feb-27-18 04:07PM  GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results GlobeNewswire
08:07AM  This could be the next $1 billion drug, if patients get on board MarketWatch
Feb-15-18 10:47AM  With an Eye on Biotech, Here's Today's Trading Thesis TheStreet.com
Feb-07-18 04:05PM  GBT Announces Participation at the Leerink Partners 7th Annual Global Healthcare Conference GlobeNewswire +6.04%
10:53AM  The Confidence in the Dip Buyers Has Weakened TheStreet.com
Feb-05-18 12:39PM  Here's Why Global Blood Therapeutics Inc. Soared 47.1% in January Motley Fool -5.06%
Jan-29-18 08:01AM  Novo Nordisk remains on hunt for biopharma deals Reuters
Jan-23-18 12:22PM  William Blair Values Global Blood Therapeutics' Stock At $80 Benzinga +6.12%
Jan-13-18 10:32AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Jan-10-18 10:31AM  Selling Action Is Upon Us TheStreet.com +17.60%
Jan-09-18 01:13PM  Healthcare Stocks Breakout: Pain Therapeutics, Inc. (PTIE), Global Blood Therapeutics Inc (GBT) SmarterAnalyst +19.07%
12:35PM  Why Global Blood Therapeutics Inc Is Rising Today Motley Fool
08:00AM  GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of Sickle Cell Disease (SCD) GlobeNewswire
Jan-03-18 04:05PM  GBT to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-22-17 09:00AM  GBT Appoints Wendy L. Yarno to Board of Directors GlobeNewswire
Dec-15-17 09:03AM  Global Blood Therapeutics Prices a $100.0 Million Common Stock Public Offering GlobeNewswire -7.99%
Dec-14-17 04:01PM  Global Blood Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire
Dec-12-17 04:59PM  Why This Biotech Stock Is Defying A Hematology-Related Pitfall Investor's Business Daily -14.24%
03:42PM  This Is Why Global Blood Therapeutics Inc. Is Sinking Today Motley Fool
11:24AM  Is Global Blood Therapeutics Incs (undefined:GBT) CEO Overpaid Relative To Its Peers? Simply Wall St.
Dec-11-17 02:25PM  Life-Shortening Blood Disease Gets Rush of Research Bloomberg
10:12AM  Morgan Stanley: Global Blood Therapeutics 'Clearly Encouraged' By Sickle Cell Therapy Data Benzinga
07:00AM  GBT Announces Presentation of Six Studies at ASH Supporting Voxelotor Sickle Cell Disease (SCD) Program GlobeNewswire
Global Blood Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. It is developing its lead product candidate, voxelotor, an oral, once-daily therapy for sickle cell disease (SCD). The company is evaluating voxelotor in SCD in a Phase III clinical trial in adult and adolescent patients with SCD. It is also evaluating the safety and pharmacokinetics of single and multiple doses of voxelotor in a Phase IIa clinical trial of adolescent and pediatric patients with SCD. Global Blood Therapeutics, Inc. was founded in 2011 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Calhoun Lesley AnnSee RemarksAug 17Sale49.1930014,756838Aug 20 08:25 PM
Calhoun Lesley AnnSee RemarksAug 16Option Exercise22.001,50033,0002,638Aug 20 08:25 PM
Calhoun Lesley AnnSee RemarksAug 16Sale50.011,70485,2141,138Aug 20 08:25 PM
LOVE TED WSee RemarksJul 16Option Exercise16.4012,194199,9821,117,979Jul 17 09:30 PM
Calhoun Lesley AnnSee RemarksJul 09Option Exercise22.002,29550,4902,683Jul 10 06:10 PM
Calhoun Lesley AnnSee RemarksJul 09Sale44.272,295101,609388Jul 10 06:10 PM
Calhoun Lesley AnnSee RemarksJul 06Option Exercise22.001,00022,0001,388Jul 10 06:10 PM
PATRICK DEVAL LDirectorJul 06Option Exercise21.4242,379907,63142,379Jul 10 06:13 PM
PATRICK DEVAL LDirectorJul 06Sale43.4042,3791,839,2830Jul 10 06:13 PM
Calhoun Lesley AnnSee RemarksJul 06Sale44.011,00044,005388Jul 10 06:10 PM
Choi JungSee RemarksMay 17Option Exercise3.401,4004,760137,477May 21 04:36 PM
Choi JungSee RemarksMay 17Sale48.253,000144,750136,077May 21 04:36 PM
Choi JungSee RemarksApr 17Option Exercise3.401,4004,760139,077Apr 19 04:05 PM
Choi JungSee RemarksApr 17Sale45.503,000136,500137,677Apr 19 04:05 PM
Choi JungSee RemarksMar 16Option Exercise3.401,4004,760140,677Mar 20 05:30 PM
Choi JungSee RemarksMar 16Sale54.153,000162,450139,277Mar 20 05:30 PM
Sham HingSee RemarksMar 07Option Exercise0.4910,7145,25098,215Mar 09 05:30 PM
Calhoun Lesley AnnSee RemarksMar 05Sale60.35995,975388Mar 05 05:00 PM
Choi JungSee RemarksFeb 16Option Exercise3.401,4004,760142,277Feb 21 06:10 PM
Choi JungSee RemarksFeb 16Sale62.953,000188,850140,877Feb 21 06:10 PM
Radovich PeterSee RemarksFeb 01Sale57.3081246,5286,817Feb 02 08:17 PM
Radovich PeterSee RemarksJan 23Option Exercise1.6130,00048,30033,581Jan 25 08:09 PM
Radovich PeterSee RemarksJan 23Sale60.0030,0001,800,0003,581Jan 25 08:09 PM
Choi JungSee RemarksJan 17Option Exercise3.401,4004,760137,778Jan 18 07:59 PM
Choi JungSee RemarksJan 17Sale52.853,000158,550134,778Jan 18 07:59 PM
Radovich PeterSee RemarksJan 10Option Exercise1.6115,00024,15017,684Jan 11 09:48 PM
Radovich PeterSee RemarksJan 10Sale50.0015,000750,0002,684Jan 11 09:48 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 19Buy38.00175,0006,650,0004,889,066Dec 19 08:22 PM
Choi JungSee RemarksDec 18Option Exercise3.401,4004,760136,655Dec 20 05:12 PM
Choi JungSee RemarksDec 18Sale36.553,000109,650135,255Dec 20 05:12 PM
Choi JungSee RemarksNov 17Option Exercise3.401,4004,760138,255Nov 21 04:30 PM
Choi JungSee RemarksNov 17Sale39.753,000119,250136,855Nov 21 04:30 PM
Radovich PeterSenior VP, OperationsOct 30Sale35.0012,500437,5000Oct 31 08:15 PM
HOMCY CHARLES JDirectorOct 27Sale34.0915,600531,77067,728Oct 27 05:15 PM
HOMCY CHARLES JDirectorOct 26Sale33.9354,4001,845,78183,328Oct 27 05:15 PM
Choi JungSee RemarksOct 17Option Exercise3.401,4004,760139,855Oct 18 06:19 PM
Choi JungSee RemarksOct 17Sale32.653,00097,950138,455Oct 18 06:19 PM
Choi JungSee RemarksSep 29Option Exercise3.401,4004,760141,455Oct 02 05:27 PM
Choi JungSee RemarksSep 29Sale30.003,00090,000140,055Oct 02 05:27 PM